Research progress in targeted chemotherapy for thyroid cancer

靳雨辰; 陈立波

doi:10.19401/j.cnki.1007-3639.2017.06.009

您当前的位置：

首页 >

文章列表页 >

Research progress in targeted chemotherapy for thyroid cancer

更新时间：2025-12-31

- Research progress in targeted chemotherapy for thyroid cancer
- China Oncology Vol. 27, Issue 6, Pages: 451-458(2017)
- 作者机构：
  
  上海交通大学附属第六人民医院核医学科,上海,200233
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2017.06.009
  CLC：
- Published Online：26 July 2017，
  
  Published：26 July 2017
- 稿件说明：
移动端阅览
靳雨辰,陈立波. 甲状腺癌靶向化疗进展[J]. 中国癌症杂志, 2017, 27(6): 451-458.

靳雨辰, 陈立波. Research progress in targeted chemotherapy for thyroid cancer[J]. China Oncology, 2017, 27(6): 451-458.
靳雨辰,陈立波. 甲状腺癌靶向化疗进展[J]. 中国癌症杂志, 2017, 27(6): 451-458. DOI： 10.19401/j.cnki.1007-3639.2017.06.009.

靳雨辰, 陈立波. Research progress in targeted chemotherapy for thyroid cancer[J]. China Oncology, 2017, 27(6): 451-458. DOI： 10.19401/j.cnki.1007-3639.2017.06.009.

摘要

由于传统治疗方法疗效所限，晚期甲状腺癌患者的死亡风险居高不下。近年来，靶向化疗在抑制甲状腺癌生长及延长患者无进展生存期上显示出良好的疗效，但也带来了一些临床困惑。该文综述了激酶抑制剂在甲状腺癌靶向化疗中的应用现状及面临的临床问题，更新甲状腺癌的治疗策略并提出未来的研究方向。

Abstract

Due to the limited efficacy of traditional therapies

the risk of death in patients with advanced thyroid cancer remains high. In recent years

targeted chemotherapy has shown prospective effects on inhibiting the growth of thyroid cancer and prolonging progression-free survival in these patients

but also brings some clinical confusion. Consequently

this paper reviewed the application status and clinical problems of targeted chemotherapy in thyroid cancer. In addition

treatment strategies of thyroid cancer and the future perspectives were also presented.

关键词

Keywords

references

Views

2780

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: advances in surgical treatment of differentiated thyroid cancer

Survival and cause-of-death analysis of 55 thousand thyroid cancer cases in China from a large single institution hospital-based cancer registry database

Research progress in epidemiology and risk factors of thyroid cancer

Current status and prospect of diagnosis and treatment of bone metastasis of thyroid cancer

Advances in basic research, clinical diagnosis and treatment of thyroid cancer in 2022

Related Author

Jugao FANG

Qian SHI

Qinghai JI

Ying ZHENG

Yu WANG

Jing YUAN

Changming ZHOU

Miao MO

Related Institution

Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University

Shanghai Engineering Research Center of Artificial Intelligence Technology for Tumor Diseases

School of Public Health, Fudan University

Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

AI问答

⁰